
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


P3 Health Partners Inc (PIII)


- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)

(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: PIII (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $14
1 Year Target Price $14
2 | Strong Buy |
0 | Buy |
2 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 236.65% | Avg. Invested days 28 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() | ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.82B USD | Price to earnings Ratio - | 1Y Target Price 14 |
Price to earnings Ratio - | 1Y Target Price 14 | ||
Volume (30-day avg) 4 | Beta 0.83 | 52 Weeks Range 5.80 - 24.73 | Updated Date 10/17/2025 |
52 Weeks Range 5.80 - 24.73 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -51.33 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -9.99% | Operating Margin (TTM) -9.59% |
Management Effectiveness
Return on Assets (TTM) -24.31% | Return on Equity (TTM) -141.55% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 181918179 | Price to Sales(TTM) 1.25 |
Enterprise Value 181918179 | Price to Sales(TTM) 1.25 | ||
Enterprise Value to Revenue 0.12 | Enterprise Value to EBITDA -1.86 | Shares Outstanding 3268218 | Shares Floating 1225418 |
Shares Outstanding 3268218 | Shares Floating 1225418 | ||
Percent Insiders 62.43 | Percent Institutions 10.64 |
Upturn AI SWOT
P3 Health Partners Inc

Company Overview
History and Background
P3 Health Partners Inc. was founded in 2016. It focuses on population health management and value-based care, partnering with physicians to improve patient outcomes and reduce healthcare costs. The company went public in 2021 via a SPAC merger.
Core Business Areas
- Value-Based Care: P3 provides a comprehensive care model that aligns financial incentives with improved health outcomes. This involves coordinating care across various providers and settings.
- Physician Partnerships: P3 partners with independent physician groups to provide them with the resources and infrastructure needed to succeed in value-based care arrangements.
- Risk Management: P3 assumes financial risk for the health outcomes of its patient population, incentivizing proactive and preventative care.
Leadership and Structure
Dr. Sherif Abdou is the CEO. The company has a board of directors and a management team responsible for overseeing various aspects of the business, including clinical operations, finance, and technology.
Top Products and Market Share
Key Offerings
- Network Management Services: P3 provides network management services to partner physicians including contracting, credentialing, and claims processing. Competitors: Optum, McKesson.
- Care Coordination: P3's care coordination services include patient outreach, chronic disease management, and transitions of care. Competitors: Signify Health, Contessa Health.
- Data Analytics Platform: P3 provides a proprietary data analytics platform that enables its partner physicians to improve patient outcomes and reduce healthcare costs through proactive and preventative care. No specific market share data available. Competitors: Cerner, Allscripts.
Market Dynamics
Industry Overview
The healthcare industry is rapidly shifting towards value-based care models, driven by the need to control costs and improve quality. This trend is creating opportunities for companies like P3 Health Partners that specialize in population health management.
Positioning
P3 Health Partners is positioned as a provider enablement company focused on value-based care. Its competitive advantage lies in its integrated care model, physician partnerships, and data analytics capabilities.
Total Addressable Market (TAM)
The TAM for value-based care is estimated to be in the trillions of dollars. P3 Health Partners is positioned to capture a portion of this market by expanding its geographic footprint and deepening its relationships with physician groups.
Upturn SWOT Analysis
Strengths
- Strong value-based care model
- Established physician partnerships
- Proprietary data analytics platform
- Experienced management team
Weaknesses
- Limited geographic footprint
- Reliance on a small number of key physician groups
- Relatively short operating history
- Dependence on accurate risk adjustment
Opportunities
- Expansion into new geographic markets
- Growth in value-based care adoption
- Acquisition of smaller physician enablement companies
- Increased government support for value-based care initiatives
Threats
- Increased competition from larger healthcare providers
- Changes in government regulations
- Economic downturn impacting healthcare spending
- Inability to accurately predict and manage risk
Competitors and Market Share
Key Competitors
- OLED
- CLOV
- AGL
Competitive Landscape
P3 Health Partners faces competition from larger, more established healthcare providers and smaller, specialized physician enablement companies. Its success depends on its ability to differentiate itself through its integrated care model and data analytics capabilities.
Growth Trajectory and Initiatives
Historical Growth: Historical growth information requires access to financial data.
Future Projections: Future projections require access to financial data and analyst estimates.
Recent Initiatives: Recent initiatives include expanding its presence in existing markets and forging new partnerships with physician groups.
Summary
P3 Health Partners is a company focused on value-based care with potential for growth in a changing healthcare landscape. Its strengths include its data-driven model and physician partnerships, but it faces challenges regarding limited market presence and reliance on key partners. Successful expansion and risk management are vital for the company's sustained growth. The company needs to watch out for market competition and changes in regulations.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
Disclaimers:
This analysis is based on publicly available information and is intended for informational purposes only. It does not constitute investment advice. Market share data is based on rough estimations.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About P3 Health Partners Inc
Exchange NASDAQ | Headquaters Henderson, NV, United States | ||
IPO Launch date 2021-04-06 | CEO, President & Director Dr. Aric Coffman M.D. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 360 | Website https://p3hp.org |
Full time employees 360 | Website https://p3hp.org |
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.